Search

Your search keyword '"Crotti, Lia"' showing total 910 results

Search Constraints

Start Over You searched for: Author "Crotti, Lia" Remove constraint Author: "Crotti, Lia"
910 results on '"Crotti, Lia"'

Search Results

151. SCN5A Mutation Type and a Genetic Risk Score Associate Variably With Brugada Syndrome Phenotype in SCN5A Families

152. Long QT Syndrome–Associated Mutations in Intrauterine Fetal Death

154. national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization — the first insight from the AC-TIVE Study.

156. Infanticide vs. inherited cardiac arrhythmias

159. Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors

160. Abnormal myocardial expression of SAP97 is associated with arrhythmogenic risk

164. MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes

165. Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION)

167. Novel Basic Science Insights to Improve the Management of Heart Failure: Review of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology

168. Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy

169. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1

170. Investigation on Sudden Unexpected Death in the Young (SUDY) in Europe: results of the European Heart Rhythm Association Survey.

171. Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19.

173. Clinical phenotypes, right ventricular function, exercise pathophysiology and outcomes of pulmonary hypertension due to left heart disease: role of the precapillary component

174. Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors.

176. A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization — the first insight from the AC-TIVE Study

177. Contributors

179. Genetic Mosaicism in Calmodulinopathy

180. SCN5A mutations in 442 neonates and children: Genotype-phenotype correlation and identification of higher-risk subgroups

181. Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population

183. Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry

184. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation

188. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene

192. International Triadin Knockout Syndrome Registry

198. The role of mitochondrial dynamics in cardiovascular diseases.

199. MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes.

200. Infanticide vs. inherited cardiac arrhythmias.

Catalog

Books, media, physical & digital resources